First Look at Combo With Immunotherapy in Untreated mRCC First Look at Combo With Immunotherapy in Untreated mRCC

The immunotherapy atezolizumab in combination with bevacizumab had some ' provocative ' phase 2 results in untreated, advanced renal cell carcinoma.Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news